Literature DB >> 35568747

The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma.

Hui Huang1, Tao Chen2, Fei Li2, Dan Jin1, Chuan Li1, Yongbo Yang1, Xuyang Liu1, Dongmiao Wang3, Jiehui Di4,5,6.   

Abstract

Renal cell carcinoma (RCC) is the most common form of malignancy affecting the kidneys. Circular RNAs (circRNAs) are non-coding RNAs that are derived from exonic or intronic sequences through a selective shearing process. There is growing evidence that these circRNAs can influence a range of biological pathways by serving as protein decoys, microRNA sponges, regulators of transcriptional activity, or templates for protein translation. The dysregulation of circRNA expression patterns is a hallmark of RCC and other cancer types, and there is strong evidence that these RNA species can play central roles in the onset and progression of RCC tumors. In the present review, we summarized recent findings on the functional roles and clinical impacts of circRNAs in RCC. Further, we discussed their potential utility as diagnostic biomarkers or targets for therapeutic intervention.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biological function; Renal cell carcinoma; Signaling; Therapeutic targets; circRNA

Mesh:

Substances:

Year:  2022        PMID: 35568747     DOI: 10.1007/s12032-022-01669-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  114 in total

1.  Exon-intron circular RNAs regulate transcription in the nucleus.

Authors:  Zhaoyong Li; Chuan Huang; Chun Bao; Liang Chen; Mei Lin; Xiaolin Wang; Guolin Zhong; Bin Yu; Wanchen Hu; Limin Dai; Pengfei Zhu; Zhaoxia Chang; Qingfa Wu; Yi Zhao; Ya Jia; Ping Xu; Huijie Liu; Ge Shan
Journal:  Nat Struct Mol Biol       Date:  2015-02-09       Impact factor: 15.369

2.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

Review 3.  First-line therapy for treatment-naive patients with advanced/metastatic renal cell carcinoma: a systematic review of published randomized controlled trials.

Authors:  Shweta Takyar; Jose Diaz; Manu Sehgal; Francisco Sapunar; Hardev Pandha
Journal:  Anticancer Drugs       Date:  2016-06       Impact factor: 2.248

4.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

5.  CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.

Authors:  Qiong Chen; Tao Liu; Yi Bao; Tangliang Zhao; Jie Wang; Hui Wang; Anbang Wang; Xinxin Gan; Zhenjie Wu; Linhui Wang
Journal:  Cancer Lett       Date:  2019-10-17       Impact factor: 8.679

6.  CircAtlas: an integrated resource of one million highly accurate circular RNAs from 1070 vertebrate transcriptomes.

Authors:  Wanying Wu; Peifeng Ji; Fangqing Zhao
Journal:  Genome Biol       Date:  2020-04-28       Impact factor: 13.583

Review 7.  Emerging important roles of circRNAs in human cancer and other diseases.

Authors:  Yong Huang; Cai Zhang; Jianli Xiong; Hongtao Ren
Journal:  Genes Dis       Date:  2020-08-07

Review 8.  Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy.

Authors:  Ying Wang; Yunjing Zhang; Ping Wang; Xianghui Fu; Weiqiang Lin
Journal:  Mol Cancer       Date:  2020-10-14       Impact factor: 27.401

Review 9.  Insights Into the Role of CircRNAs: Biogenesis, Characterization, Functional, and Clinical Impact in Human Malignancies.

Authors:  Sabah Nisar; Ajaz A Bhat; Mayank Singh; Thasni Karedath; Arshi Rizwan; Sheema Hashem; Puneet Bagga; Ravinder Reddy; Farrukh Jamal; Shahab Uddin; Gyan Chand; Davide Bedognetti; Wael El-Rifai; Michael P Frenneaux; Muzafar A Macha; Ikhlak Ahmed; Mohammad Haris
Journal:  Front Cell Dev Biol       Date:  2021-02-05
View more
  1 in total

1.  A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma.

Authors:  Rongkang Li; Chong Lu; Xinji Li; Xuan Chen; Guocheng Huang; Zhenyu Wen; Hang Li; Lingzhi Tao; Yimin Hu; Zhengping Zhao; Zebo Chen; Yongqing Lai
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.